Xnara Biologics South Asia Private Limited - Company Profile

It is a travel and hospitality foreign private limited company based in Hyderabad, Telangana, India, established in 2022.

2022 Hyderabad, Telangana, India Active

Last Updated: January 04, 2026

Access Report

About Xnara Biologics South Asia Private Limited

Xnara Biologics South Asia Private Limited, a active foreign private limited company, was established on 06 April 2022 in Hyderabad, Telangana, India. Engaging in wellness & healthcare centers within the travel and hospitality sector, it holds CIN: U15549TG2022FTC161294. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chong Huat Tan (Director), Doddy Vijay Kumar (Additional Director). Past directors included Yudishter Hakumal Bhagnani. It is based at Purva Summit, A Block,2Nd Floor, Whitefield'S, Hitech City, Hyderabad, Hyderabad, Telangana, 500081.

Company Details

CIN/LLPIN
U15549TG2022FTC161294
Registration Number
161294
Incorporation Date
06 April 2022
Authorized Capital
₹1.50 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.50 M as on 04-01-2026
Paid Up Capital ₹ 0.10 M as on 04-01-2026
Company Age 3 Year, 10 Months

Comprehensive Company Insights

Explore comprehensive insights into Xnara Biologics South Asia Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Xnara Biologics South Asia Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Chong Huat Tan	Director	06 Apr 2022	Current
Doddy Vijay Kumar	Additional Director	31 Mar 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	03 Apr 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Xnara Biologics South Asia.

Enhance accessibility to Xnara Biologics South Asia's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Xnara Biologics South Asia?

Unlock access to Xnara Biologics South Asia's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Xnara Biologics South Asia?

Xnara Biologics South Asia has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Xnara Biologics South Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xnara Biologics South Asia's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Xnara Biologics South Asia

Recent Activity within the Organization

Director Appointment

Doddy Vijay Kumar was appointed as a Additional Director was appointed as a Additional Director on 31 Mar 2023 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
31 Mar 2023
Director Appointment

The activity Chong Huat Tan was appointed as a Director was appointed as a Director on 06 Apr 2022 & has been associated with this company since 3 years 10 months . was completed.
06 Apr 2022
Company Incorporation

Xnara Biologics South Asia Private Limited was registered on 06 Apr 2022 with Roc Hyderabad & aged 3 years 10 months as per MCA records. was recorded as a recent event.
06 Apr 2022

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Xnara Biologics South Asia Private Limited?

The CIN of Xnara Biologics South Asia Private Limited is U15549TG2022FTC161294.

Where is Xnara Biologics South Asia Private Limited headquartered?

Xnara Biologics South Asia Private Limited is headquartered at Purva Summit, A Block,2Nd Floor, Whitefield'S, Hitech City, Hyderabad, Hyderabad, Telangana, 500081.

When was Xnara Biologics South Asia Private Limited incorporated?

Xnara Biologics South Asia Private Limited was incorporated on 06 April 2022.

Who are the current directors of Xnara Biologics South Asia Private Limited?

The current directors of Xnara Biologics South Asia Private Limited are

What is the primary industry of Xnara Biologics South Asia Private Limited?

The primary industry of Xnara Biologics South Asia Private Limited is Travel And Hospitality.

Is Xnara Biologics South Asia Private Limited a listed company?

Xnara Biologics South Asia Private Limited is unlisted.

What is the capital structure of Xnara Biologics South Asia Private Limited?

The authorized capital of Xnara Biologics South Asia Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available